Our Portfolio

One Mind Accelerator

Neuroblox, Inc.

Neuroblox is a computational neuroscience platform that simulates patient-specific brain and behavioral responses to clinical interventions and their targets. The platform empowers the development of new drugs and devices, and improves clinical trial success and treatment selection through precision neurotherapeutics.

Sanmai

Sanmai is a neurotechnology company developing non-invasive ultrasound neurotherapeutics for mental health and neurological disorders, combining transcranial ultrasound stimulation with AI-driven software to deliver safe and effective treatments.